Results 61 to 70 of about 14,440 (242)

Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients

Gut Pathogens, 2022
Background Gastrointestinal manifestations of coronavirus disease 2019 (COVID-19) appear to be substantial. Fecal calprotectin is a promising biomarker in COVID-19 associated gastrointestinal inflammation; however, its role in the severity of COVID-19 ...
Deasy Natalia Adriana, Titong Sugihartono, Iswan Abbas Nusi, Poernomo Boedi Setiawan, Herry Purbayu, Ummi Maimunah, Ulfa Kholili, Budi Widodo, Husin Thamrin, Amie Vidyani, Hasan Maulahela, Yoshio Yamaoka, Muhammad Miftahussurur   +12 more
doaj   +1 more source

Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease. [PDF]

, 2007
OBJECTIVE: The assessment of intestinal inflammation in patients with inflammatory bowel disease (IBD) remains a difficult challenge. Both rectal nitric oxide (NO) and fecal calprotectin can be measured using non-invasive methods and are emerging as ...
Jonkers, D., Per M. Hellström, Jon O. Lundberg, Stockbrugger, R.W., Reinders, C.I., Lundberg, J.O., Stobberingh, E.E., Daisy Jonkers, Stockbruegger, RW, Emmelie Å. Jansson, Lundberg, JO, Ellen E. Stobberingh, Reinhold W. Stockbrügger, Reinders, CI, Jansson, EA, Hellstroem, PM, Hellstrom, P.M., Jansson, E.A., Stobberingh, EE, Jonkers, D, Claudia I. Reinders   +20 more
core   +1 more source

Ocular facial myositis and sialadenitis presenting with new onset ulcerative colitis

JPGN Reports, EarlyView.
Abstract Extra‐intestinal manifestations of inflammatory bowel disease (IBD) can involve most organ systems, although the immunologic underpinnings are not well understood. Most patients who present with an extra‐intestinal manifestation have a single site of extra‐intestinal involvement; however, a small cohort presents with multiple different sites ...
Nicole Du, Nicole Mendez, Anil Darbari
wiley   +1 more source

Fecal calprotectin as a marker of gastrointestinal involvement in pediatric Henoch–Schönlein purpura patients: a retrospective analysis

BMC Pediatrics, 2020
Background Henoch–Schönlein purpura is a type of systemic vasculitis found in children. Its prognosis is usually good; however, recurrence is relatively common. If the intestines are affected, severe complications could arise.
Eun Young Paek, Dae Yong Yi, Ben Kang, Byung-Ho Choe   +3 more
doaj   +1 more source

Not all weight loss is psychiatric: Diagnostic bias in pediatric Crohn's disease

JPGN Reports, EarlyView.
Abstract Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) that can often be misdiagnosed, particularly in the female population. This is especially true in the initial stages, which are frequently characterized by weight loss and, at times, dietary intake restriction.
Karolina Aleksandra Jamrozik, Martina Begucci, Vanessa Nadia Dargenio, Nathali Bergmann, Lea Charlotte Hellberg, Hannah Franziska Schumacher, Fernanda Cristofori, Ruggiero Francavilla   +7 more
wiley   +1 more source

Can fecal calprotectin levels be used to monitor infant milk protein allergies?

Allergy, Asthma & Clinical Immunology, 2021
Background Milk protein allergy is one of the most common food allergies in infants. We aimed to test whether fecal calprotectin can be used to monitor food allergies in infants by comparing the fecal calprotectin levels in infants with a milk protein ...
Liyan Qiu, Junli Wang, Fang Ren, Lixiao Shen, Feng Li   +4 more
doaj   +1 more source

The safe and effective use of tofacitinib and ustekinumab combination therapy in infantile onset inflammatory bowel disease

JPGN Reports, EarlyView.
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan, Christian Wysocki, Bhaskar Gurram   +2 more
wiley   +1 more source

Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis

Gastroenterology Research and Practice, 2017
Objectives. Mucosal healing has become the new goal of treatment in ulcerative colitis. Fecal calprotectin has been demonstrated to differentiate between mucosal inflammation and mucosal healing.
Vendel Kristensen, Arne Røseth, Tahir Ahmad, Viggo Skar, Bjørn Moum   +4 more
doaj   +1 more source

Proactive therapeutic drug monitoring of infliximab leads to treatment durability in paediatric Crohn's disease: A single‐centre Australian experience

JPGN Reports, EarlyView.
Abstract Objectives To evaluate the durability and predictors of loss of response of infliximab (IFX) over 2 years in paediatric Crohn's disease (CD) utilizing a proactive therapeutic drug monitoring (TDM) strategy. Methods A retrospective, single‐centre cohort study was conducted at The Children's Hospital at Westmead (CHW), Australia, from January ...
Cher Wei Chuah, Jessica Eldredge, Annabel Magoffin, Edward Vincent O'Loughlin, Calvin Joomann Park, Juliana Puppi, Susan Siew, Michael Stormon, Kunal Thacker, Shoma Dutt   +9 more
wiley   +1 more source

A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis [PDF]

, 2017
Background Patients with ankylosing spondylitis (AS) are at increased risk of developing inflammatory bowel disease (IBD). We aimed to determine the variation in fecal calprotectin in AS over 5\ua0years in relation to disease activity ...
Forsblad-d\u2019Elia, Helena, Ståhl, Arne,, Klingberg, Eva,, Hans Strid, Öhman, Lena,, Deminger, Anna,, Carlsten, Hans,, Forsblad d'Elia, Helena,, St\ue5hl, Arne, Hans Carlsten, Carlsten, Hans, Strid, Hans, Eva Klingberg, Klingberg, Eva, Deminger, Anna, Anna Deminger, Forsblad-d'Elia, Helena,, Strid, Hans,, Öhman, Lena, Arne Ståhl, Lena Öhman, \ud6hman, Lena, Forsblad-d'Elia, Helena, Ståhl, Arne, Helena Forsblad-d’Elia   +24 more
core   +1 more source